Answer
No. It is a targeted protein kinase inhibitor that blocks signalling from certain abnormal NTRK or ROS1 fusion proteins.
Sources for this answer
- Rozlytrek 100 mg & 200 mg hard capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.